Validation of a Demography-Based Adaptive QT Correction Formula Using Pediatric and Adult Datasets Acquired From...

Area of Science:

• Cardiology
• Biomedical Engineering
• Pharmacology

Background:

• Standard QT correction (QTc) formulae often underperform due to demographic influences on the QT-heart rate (HR) relationship.
• Existing QTc formulae may not accurately reflect cardiac repolarization across diverse populations.
• There is a need for more accurate QTc correction methods in clinical and research settings.

Purpose of the Study:

• To develop and validate an adaptive QTc (QTcAd) formula that accounts for demographic factors.
• To compare the performance of the QTcAd formula against established QTc formulae.
• To assess the QTcAd formula's efficacy across different age groups and heart rates in humans and animals.

Main Methods:

• Developed an adaptive QTc (QTcAd) formula incorporating demographic adjustments.
• Evaluated QTcAd performance using retrospective ECG data from pediatric patients (n=1819) and the Pediatric Heart Network (n=2400).
• Validated QTcAd using in vivo (n=55) and ex vivo (n=66) guinea pig ECG recordings, including optical mapping data.

Main Results:

• The QTcAd formula consistently outperformed standard formulae (e.g., Bazett, Benatar) across all human and guinea pig age groups.
• QTcAd effectively nullified the QT-HR relationship in specific human cohorts (e.g., 20-year-olds), unlike the Bazett formula.
• QTcAd demonstrated superior accuracy in approximating optically measured pseudo-QT intervals compared to other formulae.

Conclusions:

• The demography-based QTcAd formula exhibits superior performance in both human and animal models.
• QTcAd has the potential to enhance cardiovascular disease diagnosis and risk stratification.
• This novel formula may improve the safety testing of cardiovascular drugs, particularly in pediatric populations.